The DOI matches its Crossref record; 342 of the 342 references it cites were found in a registry or an index.
Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
Open accessAbstract
Given that the PI3K/AKT pathway has manifested its compelling influence on multiple cellular process, we further review the roles of hyperactivation of PI3K/AKT pathway in various human cancers. We state the abnormalities of PI3K/AKT pathway in different cancers, which are closely related with tumorigenesis, proliferation, growth, apoptosis, invasion, metastasis, epithelial–mesenchymal transition, stem-like phenotype, immune microenvironment and drug resistance of cancer cells. In addition, we investigated the current clinical trials of inhibitors against PI3K/AKT pathway in cancers and found that the clinical efficacy of these inhibitors as monotherapy has so far been limited despite of the promising preclinical activity, which means combinations of targeted therapy may achieve better efficacies in cancers. In short, we hope to feature PI3K/AKT pathway in cancers to the clinic and bring the new promising to patients for targeted therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
15 retracted
Li, N., Miao, Y., Shan, Y., Liu, B., Li, Y., Zhao, L., & Jia, L. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.119 · Cited by 188
RetractedLiu, G., Yang, H., Liu, B., & Liu, T. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25999 · Cited by 60
RetractedTalesa, V. N., Ferri, I., Bellezza, G., Love, H. D., Sidoni, A., & Antognelli, C. (2016) · The Prostate · doi:10.1002/pros.23261 · Cited by 54
RetractedZhang, S., Wang, M., Li, Q., & Zhu, P. (2017) · Cancer Biomarkers · doi:10.3233/cbm-170620 · Cited by 46
RetractedJQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer
Qiu, H., Li, J., Clark, L. H., Jackson, A. L., Zhang, L., Guo, H., Kilgore, J. E., Gehrig, P. A., Zhou, C., & Bae-Jump, V. L. (2016) · Oncotarget · doi:10.18632/oncotarget.11631 · Cited by 45
RetractedLi, Y., Wang, Y., & Wang, Y. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27645 · Cited by 40
RetractedYan, S., Chu, D., Qiu, H., Xie, Y., Wang, C., Zhang, J., Li, W., & Guo, R. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14161 · Cited by 37
RetractedFu, J.-H., Yang, S., Nan, C.-J., Zhou, C.-C., Lu, D.-Q., Li, S., & Mu, H.-Q. (2018) · PubMed · doi:10.26355/eurrev_201801_14179 · Cited by 30
Self-citationRetractedTeng, P., Jiao, Y., Hao, M., & Tang, X. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26585 · Cited by 29
RetractedLi, G., Qin, X., Song, H., Li, Y., Qiu, Y., Cui, S., Wang, Y., Wang, H., & Gong, J. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28799 · Cited by 27
Retracted
Cited by
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Glaviano, A., Foo, A. S. C., Lam, H. Y., Yap, K. C. H., Jacot, W., Jones, R. H., Eng, H., Nair, M. G., Makvandi, P., Geoerger, B., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01827-6 · Cited by 2,138
The pathogenic role of PI3K/AKT pathway in cancer onset and drug resistance: an updated review
Rascio, F., Spadaccino, F., Rocchetti, M. T., Castellano, G., Stallone, G., Netti, G. S., & Ranieri, E. (2021) · Cancers · doi:10.3390/cancers13163949 · Cited by 497
Mesenchymal stem/stromal cells in cancer therapy
Lan, T., Luo, M., & Wei, X. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01208-w · Cited by 374
Wang, S., Zheng, Y., Yang, F., Zhu, L., Zhu, X.-Q., Wang, Z.-F., Wu, X.-L., Zhou, C.-H., Yan, J.-Y., Hu, B.-Y., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00659-4 · Cited by 369
Dysregulated phosphoinositide 3-kinase signaling in microglia: shaping chronic neuroinflammation
Chu, E., Mychasiuk, R., Hibbs, M. L., & Semple, B. D. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02325-6 · Cited by 152
Metadata
- Authors
- Jiang, N., Dai, Q., Su, X., Fu, J., Feng, X., & Peng, J.
- Venue
- Molecular Biology Reports
- Published
- 2020-04-24
- Volume
- 47
- Issue
- 6
- Pages
- 4587-4629
- ISSN
- 0301-4851 (ISSN-L)
- 1573-4978
- OpenAlex
- W3017786087
- Cited by
- 571
- References
- 342
- FWCI
- 23.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of PI3K/AKT pathway in cancer: the framework of malignant behavior. https://app.cochat.ai/papers/10.1007/s11033-020-05435-1
- The paper
- Jiang, N., Dai, Q., Su, X., Fu, J., Feng, X., & Peng, J. (2020). Role of PI3K/AKT pathway in cancer: the framework of malignant behavior. Molecular Biology Reports. https://doi.org/10.1007/s11033-020-05435-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.